Abbott has now identified the manufacturing issue that caused the fault in the sensors used in its FreeStyle Libre 3 and Libre 3 Plus CGMs. Image credit: Jonathan Weiss via Shutterstock.com. Abbott ...

Abbott has launched an effort to replace some of its FreeStyle Libre 3 continuous glucose monitors—following reports of hundreds of injuries and seven deaths worldwide—after some sensors showed they ...

The FreeStyle Libre 3 standalone reader. [Image courtesy of Abbott] Abbott (NYSE:ABT) announced today that the FDA cleared a reader device for its FreeStyle Libre 3 continuous glucose monitoring (CGM) ...

Abbott has announced that its latest continuous glucose monitor, the FreeStyle Libre 3, is now covered under Medicare. Following news in April that the FDA cleared a separate handheld reader for ...

FreeStyle Libre 3 sensors will be phased out in the UK by the end of March 2026, meaning that people living with diabetes who use the sensors will need to start using FreeStyle Libre 3 Plus sensors ...

The sensor for the next-generation FreeStyle Libre 3 CGM is the same size as two U.S. pennies stacked together. [Image courtesy of Abbott] Abbott (NYSE:ABT) has won the CE Mark in the European Union ...

The sensor for the next-generation FreeStyle Libre 3 CGM is the same size as two U.S. pennies stacked together. [Image courtesy of Abbott] Abbott (NYSE:ABT) today announced compatibility between its ...

Abbott Laboratories has scored a CE mark for the Freestyle Libre 3. The approval in Europe comes a few months after the Abbott Park, Il-based company won a nod from FDA for a second-generation version ...

The FreeStyle Libre 3 has been cleared by the FDA for people ages four and older. The new continuous glucose monitor is as small as two stacked US pennies, provides real-time readings directly to the ...